Expertise in
4
conditions

Gilles Truc

Dijon, FR 
Expertise in
4
conditions
Dijon, FR 

Overview

Gilles Truc practices practicing medicine in Dijon, France.

Mr. Truc is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Gliomatosis Cerebri, Astrocytoma, and Orchiectomy.

He is actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Dijon, 21000, France
Other Locations
Besancon, France
3, Rue De La Porte De L'Hôpital, Strasbourg, 67065, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase I/II Multicenter Trial Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and the Anti-Programmed Death-ligand 1 (PD-L1) Durvalumab (Medi4736) for Patients With Recurrent Glioblastoma (STERIMGLI)
A Phase I/II Multicenter Trial Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and the Anti-Programmed Death-ligand 1 (PD-L1) Durvalumab (Medi4736) for Patients With Recurrent Glioblastoma (STERIMGLI)
Enrollment Status: Completed
Publish Date: April 14, 2026
Intervention Type: Radiation, Drug
Study Drug: Durvalumab
Study Phase: Phase 1/Phase 2
Phase III Randomized Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma : Standard 3D Conformational Radiotherapy Versus Intensity-modulated Radiotherapy With Simultaneous-integrated Boost Guided by Magnetic Resonance Spectroscopic Imaging
Phase III Randomized Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma : Standard 3D Conformational Radiotherapy Versus Intensity-modulated Radiotherapy With Simultaneous-integrated Boost Guided by Magnetic Resonance Spectroscopic Imaging
Enrollment Status: Terminated
Publish Date: April 14, 2026
Intervention Type: Radiation
Study Phase: Phase 3
Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Intervention Type: Drug
Study Drugs: Intensified Protocol, Stupp Protocol
Study Phase: Phase 3
Validation of a Genetic Signature to Predict the Development of Sarcomas
Validation of a Genetic Signature to Predict the Development of Sarcomas
Enrollment Status: Completed
Publish Date: February 13, 2024
Intervention Type: Biological
Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation
Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation
Enrollment Status: Completed
Publish Date: January 11, 2024
Intervention Type: Other
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma: Multicentric Prospective Study
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma: Multicentric Prospective Study
Enrollment Status: Terminated
Publish Date: February 09, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
View 5 Less Clinical Trials

51 Total Publications

Long-term breast cancer risk post childhood cancer radiotherapy: data-driven screening recommendations for survivors.
Long-term breast cancer risk post childhood cancer radiotherapy: data-driven screening recommendations for survivors.
Journal: The British journal of radiology
Published: April 05, 2025

Frequently Asked Questions about Gilles Truc

Is Gilles Truc a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Gilles Truc is classified as an Advanced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gilles Truc participate in research or clinical trials?

Yes. Gilles Truc has published 51 articles and abstracts on conditions like Glioma. You can view a list of Gilles Truc's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Truc's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile